Common Contracts
6 similar Stock Option Agreement contracts by OncoCyte Corp, Biotime Inc, AgeX Therapeutics, Inc.
STOCK OPTION AGREEMENTStock Option Agreement • March 14th, 2019 • Biotime Inc • Biological products, (no disgnostic substances) • California
THIS AGREEMENT made and entered into effective as of September 17, 2018, by and between BioTime, Inc., a California corporation (the “Company”), and Brian M. Culley, an employee (the “Employee”) of the Company.
INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTStock Option Agreement • January 30th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT made and entered into as of _______, 20XX, by and between AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTStock Option Agreement • August 29th, 2018 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT made and entered into as of _______, 20XX, by and between OncoCyte Corporation, a California corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTStock Option Agreement • October 16th, 2017 • Biotime Inc • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT made and entered into as of _______, 20XX, by and between AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
STOCK OPTION AGREEMENTStock Option Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT made and entered into effective as of _______, 20__, by and between OncoCyte Corporation., a California corporation (the “Company”), and __________, an employee (the “Employee”) of the Company.
STOCK OPTION AGREEMENTStock Option Agreement • October 7th, 2015 • OncoCyte Corp • California
THIS AGREEMENT made and entered into effective as of _______, 20__, by and between OncoCyte Corporation., a California corporation (the “Company”), and __________, an employee (the “Employee”) of the Company.
